Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
US-Listed Public Company Profile built from SEC and market records · June 2026

BIO-TECHNE Corp (TECH)

$72.69 +0.19% NASDAQ: TECH · 15-min delayed
  • MINNEAPOLIS, Minnesota
  • Public · NASDAQ: TECH
  • 3,100 employees
$11.2BMarket cap
$1.2BRevenue · FY2025
$73.4MNet income
3,100Employees
TECHNASDAQ
1989IPO

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$1.2B
Net income
$73.4M
Total assets
$2.6B
Market cap
$11.2B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: TECH
$72.69 +0.19%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$43.30 $72.69

52-week range

Market cap
$11.2B
Dividend yield
0.44%
Shares outstanding
153.5M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
May 8, 1989

BIO-TECHNE Corp (TECH) Stock Price

  • Profitable — net income of $73.4M in FY2025.
  • Trading near its 52-week high.
  • Pays a dividend yielding about 0.44% annually.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review BIO-TECHNE Corp.

Write a review
Newsroom

News about BIO-TECHNE Corp

News & sentiment via Polygon.io

FAQ

BIO-TECHNE Corp: frequently asked questions

Is BIO-TECHNE Corp an American company?

Yes — BIO-TECHNE Corp is an American company headquartered in Minneapolis, Minnesota. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.

Where is BIO-TECHNE Corp headquartered?

BIO-TECHNE Corp is headquartered in Minneapolis, Minnesota, United States.

Is BIO-TECHNE Corp publicly traded?

Yes — BIO-TECHNE Corp is a publicly traded company. Its stock trades under the ticker symbol TECH on the NASDAQ.

What does BIO-TECHNE Corp do?

BIO-TECHNE Corp is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →